Elicio Therapeutics, Inc.
ELTX
$11.68
-$0.50-4.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.57M | -45.86M | -54.61M | -51.28M | -51.90M |
| Total Depreciation and Amortization | 1.13M | 1.15M | 1.15M | 1.17M | 1.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.94M | 7.01M | 13.63M | 8.68M | 9.69M |
| Change in Net Operating Assets | -3.45M | -1.20M | 4.74M | 6.37M | 3.96M |
| Cash from Operations | -36.95M | -38.90M | -35.09M | -35.07M | -37.07M |
| Capital Expenditure | -16.00K | -45.00K | -45.00K | -87.00K | -87.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 3.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.00K | -45.00K | -45.00K | -87.00K | -84.00K |
| Total Debt Issued | 9.87M | 9.87M | 29.59M | 19.73M | 19.73M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.83M | 22.19M | 24.20M | 22.45M | 23.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -549.00K | -549.00K | -549.00K |
| Cash from Financing | 36.70M | 32.06M | 53.24M | 41.63M | 42.32M |
| Foreign Exchange rate Adjustments | 48.00K | 171.00K | 168.00K | 53.00K | 22.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.00K | -6.71M | 18.28M | 6.53M | 5.19M |